204 related articles for article (PubMed ID: 33989365)
21. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma.
Chen J; Su T; Lin Y; Wang B; Li J; Pan J; Chen C
Clin Transl Oncol; 2018 Mar; 20(3):411-419. PubMed ID: 28779422
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose.
Li CC; Fang HY; Lin CY; Shen WC; Chien CR
Anticancer Res; 2019 Jan; 39(1):511-517. PubMed ID: 30591503
[TBL] [Abstract][Full Text] [Related]
24. High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial.
Lertbutsayanukul C; Kitpanit S; Kannarunimit D; Chakkabat C; Oonsiri S; Thephamongkhol K; Puataweepong P; Katanyoo K; Sukhaboon J; Tovanabut C; Chongsathientham S; Treeratsapanich P; Soonthornrak J; Prayongrat A
Trials; 2022 Oct; 23(1):897. PubMed ID: 36273186
[TBL] [Abstract][Full Text] [Related]
25. Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy.
Taniyama TK; Tsuda T; Miyakawa K; Arai H; Doi A; Hirakawa M; Horie Y; Mizukami T; Izawa N; Ogura T; Sunakawa Y; Nakajima TE
Esophagus; 2020 Jan; 17(1):67-73. PubMed ID: 31506805
[TBL] [Abstract][Full Text] [Related]
26. Survival Comparision of Three-dimensional Radiotherapy Alone vs. Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
Zhang AD; Su XH; Shi GF; Han C; Wang L; Liu H; Zhang J; Zhang RH
Arch Med Res; 2020 Jul; 51(5):419-428. PubMed ID: 32418649
[TBL] [Abstract][Full Text] [Related]
27. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
Xiang G; Xu C; Chai G; Lyu B; Li Z; Wang B; Shi M; Zhao L
Radiat Oncol; 2023 Jul; 18(1):114. PubMed ID: 37430276
[TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
Xu Y; Wang Z; Liu G; Zheng X; Wang Y; Feng W; Lai X; Zhou X; Li P; Ma H; Wang J; Hu X; Chen M
J Cancer Res Ther; 2016 Oct; 12(Supplement):82-88. PubMed ID: 27721262
[TBL] [Abstract][Full Text] [Related]
29. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.
Lin SH; Wang L; Myles B; Thall PF; Hofstetter WL; Swisher SG; Ajani JA; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1078-85. PubMed ID: 22867894
[TBL] [Abstract][Full Text] [Related]
30. Stricture rate after chemoradiotherapy and radiotherapy for oesophageal squamous cell carcinoma: a 20-year experience.
Hamer PW; Hight SC; Ward IG; Harris DL; Woodham BL; Flint RS
ANZ J Surg; 2019 Apr; 89(4):367-371. PubMed ID: 30791194
[TBL] [Abstract][Full Text] [Related]
31. Phase I Trial of Intensity-Modulated Hyperfractionated Radiotherapy Boost with Concurrent Chemotherapy Immediately Following Standard Chemoradiotherapy in Patients Primarily with Advanced Intra-thoracic/Cervical Esophageal Squamous Cell Carcinomas.
Cheng N; Liu Y; Zhao G; Xu Y; Zhang T; Chen Y; Yan G; Hu Y; Yao S; Wang Z; Wang C; Chen Z; Hu Z; Liu D; Chen T
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):340-348. PubMed ID: 31655197
[TBL] [Abstract][Full Text] [Related]
32. Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patients.
Modesto A; Dalmasso C; Lusque A; Vieillevigne L; Izar F; Moyal E; Carrère N; Guimbaud R; Rives M
Cancer Radiother; 2020 Apr; 24(2):88-92. PubMed ID: 32156457
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma: A population-based real-world study.
Zhang W; Xie Q; Zhu B; Wang X; He L; Zhang Y
Medicine (Baltimore); 2022 Apr; 101(16):e29166. PubMed ID: 35482986
[TBL] [Abstract][Full Text] [Related]
34. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study.
Elson JK; Kachnic LA; Kharofa JR
Cancer; 2018 Nov; 124(22):4383-4392. PubMed ID: 30329160
[TBL] [Abstract][Full Text] [Related]
36. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.
Koh HK; Park Y; Koo T; Park HJ; Lee MY; Chang AR; Hong S; Bae H
Anticancer Res; 2020 Mar; 40(3):1771-1778. PubMed ID: 32132086
[TBL] [Abstract][Full Text] [Related]
38. Propensity score-based comparison of survival and radiation pneumonitis after definitive chemoradiation for esophageal cancer: Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy.
Lan K; Zhu J; Zhang J; Zhou S; Yang Y; Feng Z; Zhang L; Wang S; Xi M
Radiother Oncol; 2020 Aug; 149():228-235. PubMed ID: 32474127
[TBL] [Abstract][Full Text] [Related]
39. Long-term clinical outcome of intensity-modulated radiation therapy for locally advanced esophageal squamous cell carcinoma.
Ge X; Yang X; Lu X; Wen W; Zhen F; Ye H; Zhu H; Cao Y; Zhang S; Cheng H; Ma J; Yang B; Dai S; Guo Q; Cai J; Sun X
Tumori; 2015; 101(2):168-73. PubMed ID: 25791535
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
Yang X; Wang L; Du H; Lin B; Yi J; Wen X; Geng L; Du X
Medicine (Baltimore); 2021 Jan; 100(3):e24328. PubMed ID: 33546064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]